This article is
- freely available
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany
Institute of Molecular Pathology, 1030 Vienna, Austria
These authors contributed equally.
* Author to whom correspondence should be addressed.
Received: 9 November 2010; in revised form: 1 December 2010 / Accepted: 1 December 2010 / Published: 9 December 2010
Abstract: Pancreatic carcinoma is the fourth-leading cause of cancer death and is characterized by early invasion and metastasis. The developmental program of epithelial-mesenchymal transition (EMT) is of potential importance for this rapid tumor progression. During EMT, tumor cells lose their epithelial characteristics and gain properties of mesenchymal cells, such as enhanced motility and invasive features. This review will discuss recent findings pertinent to EMT in pancreatic carcinoma. Evidence for and molecular characteristics of EMT in pancreatic carcinoma will be outlined, as well as the connection of EMT to related topics, e.g., cancer stem cells and drug resistance.
Keywords: pancreatic adenocarcinoma; epithelial-mesenchymal transition; tumor progression; cancer stem cells; chemoresistance
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Maier, H.J.; Wirth, T.; Beug, H. Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers 2010, 2, 2058-2083.
Maier HJ, Wirth T, Beug H. Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers. 2010; 2(4):2058-2083.
Maier, Harald J.; Wirth, Thomas; Beug, Hartmut. 2010. "Epithelial-Mesenchymal Transition in Pancreatic Carcinoma." Cancers 2, no. 4: 2058-2083.